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Abstract  
The benefit to have infants being delivered physiologically through vagina is amongst others to get 
maternal microbes transmission that will affect host immunity and metabolic development. 
However this mode of delivery is not always the choice to infants for several reasons. Therefore, it 
raises questions whether there is a need to give specific intervention to the caesarean section (C-
section) born infants and children for their optimal growth and development, i.e. provision of 
nutrients with or without pre-, pro- or synbiotics. Nutritional intervention is certainly important to 
support growth and development of all children, especially those born by C-section. However, in 
addition, to anticipate perturbation in the gut microbiota there is a need to prepare the C-section 
born infant through translocation from the mother’s intestinal microbiota, early initiation of 
breastfeeding and/or synbiotic supplementation formula. The superiority of synbiotic compare to 
prebiotic or probiotic alone is that synbiotic thought to have synergistic beneficial effects on the 
immune and metabolic systems in which it can compensates the delayed Bifidobacterium 
colonization modulates the production of acetate and the acidification of the gut in C-section born 
infants. However, we still need to find consistent evidence & recommendation in the world on 
synbiotic for children in general and specifically for the C-section born infant & children.  
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Introduction 
 
Pregnancy is triggering maternal inflammation due 
to several physiological changes which results in 
prenatal stress. In addition, the absence of vaginal 
microbiota caused by Caesarean section (C-section) 
delivery mode will alter infant’s gut microbiota, or 
so called dysbiosis. There are several theoretical 
outcomes of dysbiosis, in which through the increase  
 
of blood brain barrier will result to 
neuroinflammation and will cause abnormal 
neuronal/brain development. On the other hand, 
dysbiosis will result to gastro-intestinal dysfuntion 
or leaky gut that will impair the parasympathetic 
system function (i.e. vagus nerve) and will cause 
cognitive and behavioral deficits. While through 
metabolic disorder caused by dysbiosis, there will be 
disturbed cross-talk innate immune system and 
dysregulation of systemic (adaptive) immune 
system that will result to allergy and autoimmunity.1 
How could mode of delivery increase the risk of 
poor child growth and development? Although there 
is limited evidence on the association between C-
section birth and linear growth and/or brain 
development, a retrospective cohort study among 
mothers having children aged 6–24 months old in 
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Ghana found that compared to the C-section infants, 
vaginally delivered infants were 1.8 times more 
likely to receive adequate neonatal feeding, and after 
controlling for potential confounding factors, there’s 
a significant increment by 0.121 standard units on 
linear growth as measured by height-for-age 
(HAZ).2 On the other hand, a cross-sectional study 
done in East China found that 67.3% were born by 
C-section, in which 15.7% of those preschool 
children aged 3–6 years old were obese. And, after 
adjusted for parental factors, child characteristics 
and family income, the odd of overweight and 
obesity was 1.35 and 1.25 respectively.3  
Furthermore, in relation to brain development, a 
retrospective study in Arkansas Children’s Hospital 
and Brown University USA found that by using 
diffusion tensor imaging, myelin water fraction 
imaging, voxel-based morphometry, and/or resting-
state functional magnetic resonance imaging 
(fMRI), C-section delivery may influence infant 
brain development. 4  To evaluate the relation 
between C-section birth and child cognitive 
development, a longitudinal study of Australian 
children aged 4 to 9 years revealed that C-section-
born children perform significantly below by up to a 
tenth of a standard deviation in national numeracy 
test score at age 8–9 years compared to vaginally-
born children.5 To explore the mechanism on how C-
section delivery could affect child growth and 
development in relation to gut microbiota, there is 
an impact of external factors on the intestinal 
microbiota of the infant that might explain the 
mechanism from prenatal to adult-like microbiota 
through delivery mode at birth, type of feeding 
especially at the first week and first months. 6 
Finally, this article aims to find an appropriate 
solution or intervention to promote optimal growth 
and development of the C-section-born infants and 
children in the perspective of nutrition and gut 
microbiota balance. 
 
Nutritional intervention to support growth and 
development of children born by C-section 
 
It is widely agreed that human breastmilk is the gold 
standard as the first and main food for infants since 
born to be exclusively provided during the first six 
months and being continued up to 24 months of age. 
Breast milk provides complete nutrients to support 
child growth and development, regardless of 
difference in the route of delivery. Besides having 
all essential nutrients, breastmilk also consists of 
immune-components, hormones, HMOs (human 
milk oligo-saccharides, and microbiota. The HMOs 
as prebiotic and microbiota as probiotic, or synbiotic 
in breastmilk are important on their function to 
influence on the infant gut microbiota for its long-
term health benefits, e.g. lung health. Figure 1 
shows the hypothetical pathway on the association 
of HMOs as prebiotics and microbiota as probiotic 
to affect infants’ gut microbiota and lung health.7 
However, not all infants are being fortunate for 
having the breast milk, but instead will have its 
substitute, i.e. milk formula. To be updated, the milk 
formula is continued to be designed to mimic the 
breast milk, i.e. by 1) decreasing its protein content 
without changing plasma amino acid profile in 
preventing obesity; 2) supplemented with cow’s 
milk lactoferrin; 3) having long-chain PUFA 
(omega-3 and pmega-6) to promote insulin 
sensitivity, prevention of obesity and dyslipidemia; 
4) addition of milk fat globule membrane (MFGM) 
from cow’s milk to add on to the plant oil; 5) 
supplementation of prebiotic (FOS and GOS) to 
have a bifidogenic effect; and/or 6) supplemented 
with probiotic in which there is no report on its 
harmful effects.8  
The use of pre-, pro- and synbiotic in infant 
formula is done through research and innovation by 
using technological advances along with the 
development of knowledge about the component of 
breast milk. However, the evidence about its clinical 
efficacy is limited to recommend as a routine use in 
infant formula. Therefore, further research is needed 
to be able to establish their benefits for health.9 This 
recommendation is also considered to the 
inconsistency evidence, i.e. from 1) the negative 
finding of a prospective, randomized, double-blind 
controlled study among full term infants with 
diagnosed cow’s mild allergy (CMA) who received 
synbiotic supplemented amino acid-based formula 
(AAF) that showed similar growth to the AAF 
without synbiotics;10 to the positive finding from a 
randomized, double-blind, multicenter study on the 
effect of synbiotic on the microbiota of caesarean 
delivery infants in which supplementation with 
short-chain galacto-oligosaccharides/long-chain 
fructo-oligosaccharides and Bifidobacterium 
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breveM-16V compensates the delay 
Bifidobacterium colonization in C-section-delivered 
infants and modulates the production of acetate and 
the acidification of the gut. Physiologically, it 
reveals as indicator of gut health, emulate those 
observed in vaginally born infants.11 
 
Superiority of synbiotic compare to prebiotic or 
probiotic intervention alone on C-section born 
children 
 
There are things to consider regarding to the needs 
to provide synbiotic intervention. Several studies 
showed the effects of antibiotic treatment in the pre-
natal period and early post-natal life in the gut 
microbiota, as well as on the risk of wheeze and 
asthma. While it also evidence that there are 
maternal factors influencing the composition of 
breast milk microbiota, and among others is C-
section. All of those will induce dysbiosis condition 
and increase the risk of allergy.12  
The dysbiosis in children born by C-section is 
influenced by several factors, i.e. extremes of 
maternal body mass index (BMI), preterm birth, 
extremes of infants’ size, infection, and gestational 
diabetes. The impact of microbial dysbiosis caused 
by C-section delivery is linked with an increased risk 
of inflammatory bowel disease (IBD) and a wide 
range of autoimmune, allergic and metabolic 
condition, as shown in Figure 2.13 
What are the potential for pre-, pro- or synbiotics 
in the management of infants at risk of dysbiosis? 
The use of prebiotic is due to its potential effect in 
selectively utilized by host microorganisms 
conferring a health benefit. While probiotic as live 
organisms has it potential when administered in 
adequate amount confer a health benefit on the host. 
Furthermore, synbiotic as a mixture of pre- and 
probiotics potentially affects the host by improving 
the survival and implantation of live microbial 
dietary supplements in the gastrointestinal tract, 
improving the health of the host. 14  It has been 
recommended that during pregnancy, a probiotic 
treatment may represent an effective strategy to 
promote a healthy microbial composition in C-
section born infants, while also to give prebiotic 
supplementation in infants exposed to early-life 
microbial perturbation, such as a C-section born 
infant. Furthermore, the combination of pre- and 
probiotics or synbiotics is thought to have 
synergistic beneficial effects on the immune and 
metabolic systems.15 Thus, synbiotic should have a 
greater effect than the prebiotic or probiotic alone as 
shown in Figure 3 on the mechanism of action and 
their effects.16 
Regarding to the mechanism of action, then 
while providing the synbiotic intervention to the C-
section born infants and children, we should 
consider to give nutritional modulation of maternal 
microbiota that might influence the development of 
the infant gastrointestinal tract. Using a hypothetical 
model, we can learn how maternal microbiota and 
microbial products could be transferred from mother 
to the fetal and neonatal gastrointestinal tract. It 
shows that dendritic cells can cross the paracellular 
space of the intestinal epithelium to take up bacteria 
directly from the intestine lumen. Following to that 
action then circulation of lymphocytes within the 
mucosal associated lymphoid tissue allows the 
maternal gastrointestinal tract microbiota to reach 
distant mucosal surfaces, including those found in 
the genitourinary and respiratory tracts, lactating 
mammary gland, salivary and lachrymal glands, as 
shown in Figure 4.17 
This explanation inspires us to manipulate the 
maternal gastrointestinal microbiota composition 
through the use of pro-, pre or synbiotic and its 
subsequent impacts for the health of the newborn. 
To confirm the hypothesis, an Indonesian study can 
show the effect of probiotic provided to pregnant 
women since the 3rd trimester can be found in the 
colostrum and the 3-month breast milk.18  
Finally, regarding to the composition of 
symbiotic, although we have already been informed 
on the properties of several microorganism 
considered as probiotics (such as Lactobacillus and 
Bifidobacterium), and prebiotics (such as 
oligosaccharides, i.e. FOS and GOS), however we 
still need further information on its combination as 
a synbiotic. So far, the most used and already 
marketed synbiotics are mixtures of 
oligosaccharides FOS and GOS with probiotics 
bacterial strain L. plantarum, L. paracasei, L. 
rhamnosus, B. bifidum or B. lactis that have been 
selected for the functional activities in the context of 
a specific combination formulation with 
prebiotics.19 Several studies that showed a synbiotic 
combination of L. casei and dextran prevented the 
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cedar-pollen induced onset of nasal and ocular 
symptoms, and a combination of potato starch and 
L. rhamnosus reduced a disease score of atopic 
dermatitis, showing that there are specific 
synergistic effects of a combination of certain 
synbiotics. Therefore, future research should 
provide clinical evidence of certain combination 
formulation of synbiotics, especially to overcome 
dysbiosis resulted by the C-section. 
 
Conclusion 
 
Beside breast-feeding, translocation from the 
mother’s intestinal microbiota and synbiotic 
supplementation are amongst nutritional 
intervention to support growth and development of 
C-section born infants and children. Regarding to 
the fact that synbiotic is thought to have synergistic  
beneficial effects on the immune and metabolic 
systems by compensated the delayed 
Bifidobacterium colonization in C-section born 
infants and modulates the production of acetate and 
the acidification of the gut, therefore, symbiotic for 
children in general and specifically for C-section 
infants and children may have an impact on healthy 
young children gut microbiota, although further 
research is certainly needed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Hypothetical pathways of association between breastfeeding and lung health7 
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Figure 2. Contributing factors and conditions linked to C-section delivery13 
 
 
 
Figure 3. Mechanism of actions of synbiotics and their effects 
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Figure 4. A hypothetical model of how maternal microbiota and microbial products may be transferred from mother to fetal’s 
and neonatal’s gastrointestinal tract 
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